Ross Dobinson
Managing Director
BBus
Ross Dobinson has extensive corporate advisory and investment banking experience. Ross has also taken an entrepreneurial role in the commercialisation of technologies in a range of fields, including: agricultural science, pharmaceuticals, environmentally-friendly packaging, medical devices, drug delivery technology and nutriceuticals. Ross has experience in company formation, seed, mezzanine and IPO funding, specialising in the life sciences sector, where he has been a founding director, investor and executive of listed and unlisted companies.

Commencing as a chartered accountant with Hungerfords, Ross has held positions as a Director of the listed stockbroking firm of Jacksons Limited, Head of Corporate Advisory Services at the stockbroking firm operated by National Australia Bank Limited (A.C. Goode & Co. Ltd), Director of National Australia Corporate Advisory Limited, and Director of Corporate Advisory of Dresdner Australia Proprietary Limited.

Ross has taken two highly successful biotechnology companies from pre-seed stage to listed status with a current market capitalisation of over $275 million.  In addition, Ross has been involved in venture capital initiatives in Australia, Europe and the United States.

Ross has a Bachelor of Business Degree from Queensland University of Technology.  He is currently Chairman of:

• Acrux Limited
• Horizon Science Pty Ltd
• Micronix Pty Ltd
• Diagnotech Pty Ltd
• Farm By Nature Pty Ltd
• TPI Enterprises Ltd
• Etech Group International Ltd

He is also a Director of:

• Starpharma Holdings Limited
• Origin Capital Limited
• PharmaQest Pty Ltd
• Healthfarm Fine Foods Pty Ltd